Dec 26, 2025
Nvidia Stock Climbs As The King Of AI Defends Its Throne

NVIDIA Corp. (NASDAQ:NVDA) made a key move on Wednesday to secure its dominance in the AI inference market through a non-exclusive licensing agreement with Groq.  NVDA stock is climbing. See the chart and price action here.  Analysts at Rosenblatt Securities…

Dec 26, 2025
What’s Going On With Adicet Bio Stock Today?

Shares of Adicet Bio, Inc. (NASDAQ:ACET) are trading lower after the clinical stage biotechnology company announced a one-for-16 reverse stock split. Adicet Bio stock is taking a hit today. Why is ACET stock dropping? The move, expected to take effect on…

Dec 26, 2025
China Sanctions Boeing, Northrop, Anduril Founder

China on Friday imposed sanctions on 20 U.S. defense companies and 10 executives, escalating tensions with Washington over Taiwan and deepening the broader U.S.-China strategic rivalry. The measures target firms including Northrop Grumman Corp. (NYSE:NOC), L3Harris Technologies, Inc.’s (NYSE:LHX), Maritime…

Dec 26, 2025
ECD Auto Design Expands 2026 Lineup With Heritage Coupes, Classic SUVs

ECD Auto Design Inc. (NASDAQ:ECDA) announced on Friday a major expansion of its 2026 product lineup, encompassing heritage-inspired coupes, classic SUVs, and modern lifestyle 4x4s. The company said the expanded roadmap introduces new model families, deeper engineering refinement, and broader…

Dec 26, 2025
What’s Going On With Aptevo Therapeutics Stock Today?

Shares of Aptevo Therapeutics Inc. (NASDAQ:APVO) are trading lower Friday after the Seattle-based company announced a one-for-eighteen reverse stock split. What To Know: Every 18 shares of common stock issued and outstanding will be converted into one share of common…

Dec 26, 2025
Johnson & Johnson Halts Atopic Dermatitis Study After Interim Analysis Miss

On Friday, Johnson & Johnson (NYSE:JNJ) shared the planned interim analysis from Phase 2b DUPLEX-AD proof-of-concept study of JNJ-95475939 for moderate to severe atopic dermatitis (AD). Atopic dermatitis or eczema is a chronic skin condition causing dry, intensely itchy, inflamed,…

Dec 26, 2025
ImmuCell Puts Re-Tain On Pause After FDA Letter

Animal health firm ImmuCell Corporation (NASDAQ:ICCC) received an Incomplete Letter from the United States Food and Drug Administration (FDA) on Tuesday for its Re-Tain New Animal Drug Application (NADA). Re-Tain is the company’s intramammary treatment for subclinical mastitis in lactating…